גליום ציטראט
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
GALLIUM (67GA) CITRATE; SODIUM CITRATE
Available from:
ISORAD LTD, ISRAEL
ATC code:
V09HX01
Pharmaceutical form:
תמיסה להזרקה
Composition:
GALLIUM (67GA) CITRATE 1.5 - 2 MCI; SODIUM CITRATE 1.5 - 2 MG
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
ISORAD LTD., ISRAEL
Therapeutic group:
GALLIUM (67GA) CITRATE
Therapeutic area:
GALLIUM (67GA) CITRATE
Therapeutic indications:
Inflammatory lesions and abscesses. Primary and metastatic tumors Hodgkin's disease. Lymphomas and brochogenic carcinoma.
Authorization date:
2015-12-31
